>>> US Gapping up

Gapping up
In reaction to earnings/guidance:

TEAM +22.4%, TWLO +17.6%, WEAV +16.5%, FIVN +14.9% (also $90 mln accelerated share repurchase; new $200 mln share repurchase program), RDDT +13.9%, NVT +10.6%, EL +9.9%, BOOM +9.8%, CERS +9%, TRUP +8.4%, ROKU +8.1%, MATW +7.3%, MRNA +6.4%, ZETA +6.3%, MTZ +5.4%, SBGI +5.1%, PRLB +4.9%, DBVT +4.8%, HUN +4.7%, GDDY +4%, NEWT +3.9%, JAKK +3.9%, MMSI +3.9%, ENSG +3.8%, HG +3.8%, AAPL +3.7% (also increases dividend 4%; authorizes additional program to repurchase up to $100 bln of common stock), OLED +3.5% (also authorizes new $400 mln share repurchase program), EBS +3.4%, CHD +3.4%, KIDS +3.3%, COLM +3.2%, ALGT +3.1%, BTSG +3%, HR +2.9%, SNDR +2.9%, NWL +2.9%, TEX +2.9%, ACA +2.8%, CVEO +2.6%, AON +2.6%, AMG +2.5%, RIOT +2.4%, LEA +2.3%, ACCO +2.2%, EMN +2%, DRH +2% (also authorizes new $300 mln share repurchase program), MGA +2%, CL +2%, GDYN +1.8%, TRP +1.8%, SHEN +1.7%, SPSC +1.6%, PK +1.6%, PSO +1.5%, ARES +1.2%, KWR +1.1%

Other news:

VEEV +9.8% (to join S&P 500)
MFI +3.6% (to delay 20-F filing)
TWO +3.3% (UWMC issues open letter to Two Harbors stockholders detailing new $12 per share offer)
CTNM +3% (reports topline data from PIPE-791 phase 1b trial)
MPLT +2.7% (announces completion of enrollment in ZEPHYR phase 2 trial and updates expected timing of topline results)
GEN +1.9% (launches VPN for Agents)
RYTM +1.9% (confirms that the EC expanded the marketing authorization for IMCIVREE (setmelanotide) to include the treatment of obesity and control of hunger in adults and children 4 years of age and above with acquired hypothalamic obesity due to hypothalamic injury or impairment)
XE +1.7% (PPL units and XE are collaborating to explore deploying Xe-100 small modular reactor in Kentucky)
BHR +1.7% (to sell the Park Hyatt Beaver Creek Resort)
CHCT +1.7% (raises quarterly dividend to $0.48 per share)
CWT +1.7% (California Water Service receives CPUC rate case decision, approves increases)
TXT +1.2% (selected by Near Earth Autonomy as a partner)